Loading...

Anne Louise Peters, MD

Title(s)Professor of Medicine (Clinical Scholar)
Address2020 Zonal Avenue
Off Campus
Los Angeles CA 90033
Phone+1 310 657 3030
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    American Association for the Advancement of Science1974Research Award
    1980National Institutes of Health Summer Research Award
    American Medical Women's Association1983Citation for Scholastic Achievement
    American College of Physicians1991Fellow
    Cedars-Sinai Medical Center1991Morris Press Humanism Award
    2001  - 2004Best Doctors in America
    Diabetes Management Clinic2004Honorable Mention
    2004Safety Net Award
    American Diabetes Association2008Outstanding Physician Clinician Award
    National Minority Quality Forum2010Bernardo Alberto Houssay Award

    Collapse Overview 
    Collapse Overview
    Anne Peters, M.D., is Professor of Medicine at the Keck School of Medicine of USC and Director of the USC Clinical Diabetes Programs. Dr. Peters earned her medical degree from the Pritzker School of Medicine at the University of Chicago and performed an internal medicine residency at Stanford University and an endocrinology fellowship at Cedars-Sinai Medical Center. She previously directed the clinical diabetes programs at Cedars-Sinai and UCLA. Her research has focused on testing new approaches for diagnosing and treating diabetes and developing systems of care to improve outcomes in diabetic populations.

    She has published over 200 articles, reviews, and abstracts and three books on diabetes. She has been an investigator on over 40 research studies and has spoken at over 400 programs throughout the US as well as internationally. She has served on many committees for the ADA and other organizations. Currently she is the chair of the Endocrine Society Committee on Diabetes Devices and is on the EASD/ADA Technology Safety Committee. Additionally she is a member of the JDRF Panel on Management of Exercise in Type 1 Diabetes. She is a member of the ABIM Endocrinology Subspecialty Board. She consults for many entities, including the FDA, Optum Rx and CVS/Caremark to help guide the development and use of treatments for diabetes.

    Collapse Research 
    Collapse Research Activities and Funding
    15/16 Action for Health in Diabetes Extension Study Research Project
    NIH U01DK057219Sep 30, 1999 - Sep 29, 2011
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Comparison of Protocols to Reduce Diabetic Ketoacidosis in Patients With Type 1 Diabetes Prescribed a Sodium-Glucose Cotransporter 2 Inhibitor. Diabetes Spectr. 2021 Jan; 34(1):42-51. Teng R, Kurian M, Close KL, Buse JB, Peters AL, Alexander CM. PMID: 33627993.
      View in: PubMed   Mentions:
    2. Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies. Diabetes Care. 2020 Nov; 43(11):2713-2720. Peters AL, McGuire DK, Danne T, Kushner JA, Rodbard HW, Dhatariya K, Sawhney S, Banks P, Jiang W, Davies MJ, Lapuerta P. PMID: 32928957.
      View in: PubMed   Mentions:    Fields:    
    3. The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth. Diabetes Technol Ther. 2020 Jun; 22(6):449-453. Peters AL, Garg SK. PMID: 32383989.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    4. Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial. Diabetes Obes Metab. 2020 07; 22(7):1083-1093. Frias JP, Gonzalez-Galvez G, Johnsson E, Maaske J, Testa MA, Simonson DC, Dronamraju N, Garcia-Sanchez R, Peters AL. PMID: 32052516.
      View in: PubMed   Mentions: 2     Fields:    
    5. Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetologia. 2020 02; 63(2):229-241. Fleming GA, Petrie JR, Bergenstal RM, Holl RW, Peters AL, Heinemann L. PMID: 31802144.
      View in: PubMed   Mentions:
    6. Extended-Release Formulation and Medication Adherence. J Gen Intern Med. 2020 01; 35(1):354-356. Romley JA, Xie Z, Chiou T, Goldman D, Peters AL. PMID: 31659657.
      View in: PubMed   Mentions:    Fields:    
    7. Integration of Diabetes Technology in Clinical Practice. Endocrinol Metab Clin North Am. 2020 03; 49(1):69-77. Peters AL. PMID: 31980122.
      View in: PubMed   Mentions: 1     Fields:    
    8. Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetes Care. 2020 01; 43(1):250-260. Fleming GA, Petrie JR, Bergenstal RM, Holl RW, Peters AL, Heinemann L. PMID: 31806649.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    9. Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH). J Clin Endocrinol Metab. 2019 12 01; 104(12):6279-6290. Cohan P, East HE, Galati SJ, Mercado JU, Lim PJ, Lamerson M, Smith JJ, Peters AL, Yuen KCJ. PMID: 31112270.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. The Affordable Care Act and Health Insurance Coverage Among People With Diagnosed and Undiagnosed Diabetes: Data From the National Health and Nutrition Examination Survey. Diabetes Care. 2019 11; 42(11):e179-e180. Myerson R, Romley J, Chiou T, Peters AL, Goldman D. PMID: 31548249.
      View in: PubMed   Mentions: 1     Fields:    
    11. Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12?weeks: The inTandem4 trial. Diabetes Obes Metab. 2019 11; 21(11):2440-2449. Baker C, Wason S, Banks P, Sawhney S, Chang A, Danne T, Gesty-Palmer D, Kushner JA, McGuire DK, Mikell F, O'Neill M, Peters AL, Strumph P. PMID: 31264767.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Management of Preexisting Diabetes in Pregnancy: A Review. JAMA. 2019 05 14; 321(18):1811-1819. Alexopoulos AS, Blair R, Peters AL. PMID: 31087027.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Baseline nocturnal glucose change: A predictor of the treatment effect of bolus intensification in insulin-treated type 2 diabetes. Diabetes Obes Metab. 2019 07; 21(7):1752-1756. Peters AL, Piletic M, Ejstrud J, Salvesen-Sykes K, Snyder J, Bowering K. PMID: 30924578.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program. Diabetes Care. 2019 05; 42(5):919-930. Danne T, Cariou B, Buse JB, Garg SK, Rosenstock J, Banks P, Kushner JA, McGuire DK, Peters AL, Sawhney S, Strumph P. PMID: 30833371.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    15. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors. Diabetes Care. 2019 Jun; 42(6):1147-1154. Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, Alexander CM, Battelino T, Ampudia-Blasco FJ, Bode BW, Cariou B, Close KL, Dandona P, Dutta S, Ferrannini E, Fourlanos S, Grunberger G, Heller SR, Henry RR, Kurian MJ, Kushner JA, Oron T, Parkin CG, Pieber TR, Rodbard HW, Schatz D, Skyler JS, Tamborlane WV, Yokote K, Phillip M. PMID: 30728224.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    16. The Changing Definition of a Primary Care Provider. Ann Intern Med. 2018 12 18; 169(12):875-876. Peters AL. PMID: 30458467.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Psychosocial and Behavioral Correlates of A1C and Quality of Life Among Young Adults With Diabetes. Diabetes Educ. 2018 12; 44(6):489-500. Vigen CLP, Carandang K, Blanchard J, Sequeira PA, Wood JR, Spruijt-Metz D, Whittemore R, Peters AL, Pyatak EA. PMID: 30295170.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines. J Endocr Soc. 2018 Nov 01; 2(11):1214-1225. Peters AL, Ahmann AJ, Hirsch IB, Raymond JK. PMID: 30324178.
      View in: PubMed   Mentions:
    19. Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study. Diabetes Technol Ther. 2018 10; 20(10):639-647. Akturk HK, Snell-Bergeon JK, Rewers A, Klaff LJ, Bode BW, Peters AL, Bailey TS, Garg SK. PMID: 30207748.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol. Diabetes Technol Ther. 2018 09; 20(9):571-575. Garg SK, Peters AL, Buse JB, Danne T. PMID: 30129772.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    21. Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange. Diabetes Technol Ther. 2018 08; 20(8):517-523. Polsky S, Wu M, Bode BW, DuBose SN, Goland RS, Maahs DM, Foster NC, Peters AL, Levy CJ, Shah VN, Beck RW. PMID: 29990438.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    22. T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes. Diabetes Care. 2018 09; 41(9):1862-1869. Fisher L, Hessler D, Polonsky WH, Masharani U, Guzman S, Bowyer V, Strycker L, Ahmann A, Basina M, Blumer I, Chloe C, Kim S, Peters AL, Shumway M, Weihs K, Wu P. PMID: 29976567.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    23. Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study. Diabetes Care. 2018 Sep; 41(9):1970-1980. Buse JB, Garg SK, Rosenstock J, Bailey TS, Banks P, Bode BW, Danne T, Kushner JA, Lane WS, Lapuerta P, McGuire DK, Peters AL, Reed J, Sawhney S, Strumph P. PMID: 29937430.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    24. HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study. Diabetes Care. 2018 Sep; 41(9):1981-1990. Danne T, Cariou B, Banks P, Brandle M, Brath H, Franek E, Kushner JA, Lapuerta P, McGuire DK, Peters AL, Sawhney S, Strumph P. PMID: 29937431.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    25. A Physician's Place in the #MeToo Movement. Ann Intern Med. 2018 05 01; 168(9):676-677. Peters AL. PMID: 29710264.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Impact of Intensive Lifestyle Intervention on Disability-Free Life Expectancy: The Look AHEAD Study. Diabetes Care. 2018 05; 41(5):1040-1048. Gregg EW, Lin J, Bardenheier B, Chen H, Rejeski WJ, Zhuo X, Hergenroeder AL, Kritchevsky SB, Peters AL, Wagenknecht LE, Ip EH, Espeland MA. PMID: 29545462.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    27. Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 Trials. Diabetes Obes Metab. 2018 06; 20(6):1490-1498. Pozzilli P, Leslie RD, Peters AL, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J, Martin S, Schloot NC. PMID: 29377522.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    28. Occupational Therapy Intervention Improves Glycemic Control and Quality of Life Among Young Adults With Diabetes: the Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) Randomized Controlled Trial. Diabetes Care. 2018 04; 41(4):696-704. Pyatak EA, Carandang K, Vigen CLP, Blanchard J, Diaz J, Concha-Chavez A, Sequeira PA, Wood JR, Whittemore R, Spruijt-Metz D, Peters AL. PMID: 29351961.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    29. Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care. 2017 12; 40(12):1614-1621. Petrie JR, Peters AL, Bergenstal RM, Holl RW, Fleming GA, Heinemann L. PMID: 29070577.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    30. Rethinking Rates of Undiagnosed Diabetes: The Value of a Confirmatory Test. Ann Intern Med. 2017 12 05; 167(11):822-823. Peters AL. PMID: 29059685.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. The relationship between adherence and total spending among Medicare beneficiaries with type 2 diabetes. Am J Manag Care. 2017 Apr; 23(4):248-252. MacEwan JP, Sheehan JJ, Yin W, Vanderpuye-Orgle J, Sullivan J, Peneva D, Kalsekar I, Peters AL. PMID: 28554205.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes. Diabetes Care. 2017 Apr; 40(4):538-545. Aleppo G, Ruedy KJ, Riddlesworth TD, Kruger DF, Peters AL, Hirsch I, Bergenstal RM, Toschi E, Ahmann AJ, Shah VN, Rickels MR, Bode BW, Philis-Tsimikas A, Pop-Busui R, Rodriguez H, Eyth E, Bhargava A, Kollman C, Beck RW, . PMID: 28209654.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    33. Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) study: Methodology and baseline characteristics of a randomized controlled trial evaluating an occupation-based diabetes management intervention for young adults. Contemp Clin Trials. 2017 03; 54:8-17. Pyatak EA, Carandang K, Vigen C, Blanchard J, Sequeira PA, Wood JR, Spruijt-Metz D, Whittemore R, Peters AL. PMID: 28064028.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    34. Health Care Transition Preparation and Experiences in a U.S. National Sample of Young Adults With Type 1 Diabetes. Diabetes Care. 2017 Mar; 40(3):317-324. Garvey KC, Foster NC, Agarwal S, DiMeglio LA, Anderson BJ, Corathers SD, Desimone ME, Libman IM, Lyons SK, Peters AL, Raymond JK, Laffel LM. PMID: 28007779.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    35. Four-Year Physical Activity Levels among Intervention Participants with Type 2 Diabetes. Med Sci Sports Exerc. 2016 12; 48(12):2437-2445. Unick JL, Gaussoin SA, Hill JO, Jakicic JM, Bond DS, Hellgren M, Johnson KC, Peters AL, Coday M, Kitzman DW, Bossart S, Wing RR. PMID: 27471785.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    36. Hypoglycemia in Older Adults with Type 1 Diabetes. Diabetes Technol Ther. 2016 12; 18(12):765-771. DuBose SN, Weinstock RS, Beck RW, Peters AL, Aleppo G, Bergenstal RM, Rodriguez H, Largay JF, Massaro EM, Hirsch IB. PMID: 27996319.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    37. The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes. Diabetes Care. 2017 Feb; 40(2):171-180. Rodbard HW, Peters AL, Slee A, Cao A, Traina SB, Alba M. PMID: 27899497.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    38. Clinical and Psychosocial Outcomes of a Structured Transition Program Among Young Adults With Type 1 Diabetes. J Adolesc Health. 2017 Feb; 60(2):212-218. Pyatak EA, Sequeira PA, Vigen CL, Weigensberg MJ, Wood JR, Montoya L, Ruelas V, Peters AL. PMID: 27889401.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    39. Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease. PLoS One. 2016; 11(10):e0163627. Chen F, Su W, Becker SH, Payne M, Castro Sweet CM, Peters AL, Dall TM. PMID: 27706216.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    40. Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016 Nov; 101(11):3922-3937. Peters AL, Ahmann AJ, Battelino T, Evert A, Hirsch IB, Murad MH, Winter WE, Wolpert H. PMID: 27588440.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    41. The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older. J Diabetes Sci Technol. 2016 07; 10(4):892-7. Polonsky WH, Peters AL, Hessler D. PMID: 27022095.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    42. Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes. Diabetes Care. 2016 Apr; 39(4):532-8. Peters AL, Henry RR, Thakkar P, Tong C, Alba M. PMID: 26989182.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    43. Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes. Diabetes Care. 2016 Apr; 39(4):603-10. Weinstock RS, DuBose SN, Bergenstal RM, Chaytor NS, Peterson C, Olson BA, Munshi MN, Perrin AJ, Miller KM, Beck RW, Liljenquist DR, Aleppo G, Buse JB, Kruger D, Bhargava A, Goland RS, Edelen RC, Pratley RE, Peters AL, Rodriguez H, Ahmann AJ, Lock JP, Garg SK, Rickels MR, Hirsch IB, . PMID: 26681721.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    44. Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition. Diabetes Care. 2015 Sep; 38(9):1687-93. Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. PMID: 26078479.
      View in: PubMed   Mentions: 140     Fields:    Translation:Humans
    45. Let's Empower and Prepare (LEAP): Evaluation of a Structured Transition Program for Young Adults With Type 1 Diabetes. Diabetes Care. 2015 Aug; 38(8):1412-9. Sequeira PA, Pyatak EA, Weigensberg MJ, Vigen CP, Wood JR, Ruelas V, Montoya L, Cohen M, Speer H, Clark S, Peters AL. PMID: 25906787.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    46. Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 2014;37:2702-2709. Diabetes Care. 2015 Apr; 38(4):e61. Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB, Kleis L, Chase HP, DuBose SN, Miller KM, Beck RW, Adi S, . PMID: 25805875.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care. 2015 Apr; 38(4):716-22. Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. PMID: 25776138.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    48. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetologia. 2015 May; 58(5):862-70. Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. PMID: 25784563.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    49. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2015 Mar; 58(3):429-42. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. PMID: 25583541.
      View in: PubMed   Mentions: 173     Fields:    Translation:Humans
    50. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015 Jan; 38(1):140-9. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. PMID: 25538310.
      View in: PubMed   Mentions: 669     Fields:    Translation:HumansPHPublic Health
    51. Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes. Diabetes Care. 2015 Mar; 38(3):476-81. Davis AK, DuBose SN, Haller MJ, Miller KM, DiMeglio LA, Bethin KE, Goland RS, Greenberg EM, Liljenquist DR, Ahmann AJ, Marcovina SM, Peters AL, Beck RW, Greenbaum CJ, . PMID: 25519448.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    52. Patient perspectives on peer mentoring: type 1 diabetes management in adolescents and young adults. Diabetes Educ. 2015 02; 41(1):59-68. Lu Y, Pyatak EA, Peters AL, Wood JR, Kipke M, Cohen M, Sequeira PA. PMID: 25394732.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    53. Primary care medical home experience and health-related quality of life among adult medicaid patients with type 2 diabetes. J Gen Intern Med. 2015 Feb; 30(2):161-8. Stevens GD, Shi L, Vane C, Nie X, Peters AL. PMID: 25316585.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    54. Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes. Diabetes Care. 2014 Sep; 37(9):2548-56. Espeland MA, Glick HA, Bertoni A, Brancati FL, Bray GA, Clark JM, Curtis JM, Egan C, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Hazuda HP, Hill JO, Hire D, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Killean T, Kitabchi AE, Knowler WC, Kriska A, Lewis CE, Miller M, Montez MG, Murillo A, Nathan DM, Nyenwe E, Patricio J, Peters AL, Pi-Sunyer X, Pownall H, Redmon JB, Rushing J, Ryan DH, Safford M, Tsai AG, Wadden TA, Wing RR, Yanovski SZ, Zhang P, . PMID: 25147253.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    55. GLP-1 provoked severe hypoglycemia in an individual with type 2 diabetes and a benign insulinoma. Diabetes Care. 2014 Aug; 37(8):e177-8. Ruby RJ, Armato JP, Pyke C, Peters AL. PMID: 25061148.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. The Look AHEAD Trial: bone loss at 4-year follow-up in type 2 diabetes. Diabetes Care. 2014 Oct; 37(10):2822-9. Lipkin EW, Schwartz AV, Anderson AM, Davis C, Johnson KC, Gregg EW, Bray GA, Berkowitz R, Peters AL, Hodges A, Lewis C, Kahn SE, . PMID: 25048381.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    57. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014 Oct; 37(10):2702-9. Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB, Kleis L, Chase HP, DuBose SN, Miller KM, Beck RW, Adi S, . PMID: 25011947.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    58. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014 Jul; 37(7):2034-54. Chiang JL, Kirkman MS, Laffel LM, Peters AL, . PMID: 24935775.
      View in: PubMed   Mentions: 184     Fields:    Translation:Humans
    59. Healthcare costs and adherence associated with human regular U-500 versus high-dose U-100 insulin in patients with diabetes. Endocr Pract. 2014 Jul; 20(7):663-70. Eby EL, Zagar AJ, Wang P, Curtis BH, Xie J, Haldane DC, Idris I, Peters AL, Hood RC, Jackson JA. PMID: 24449672.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    60. Do experiences consistent with a medical-home model improve diabetes care measures reported by adult Medicaid patients? Diabetes Care. 2014 Sep; 37(9):2565-71. Stevens GD, Shi L, Vane C, Peters AL. PMID: 24947789.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    61. Depression in adults in the T1D Exchange Clinic Registry. Diabetes Care. 2014 Jun; 37(6):1563-72. Trief PM, Xing D, Foster NC, Maahs DM, Kittelsrud JM, Olson BA, Young LA, Peters AL, Bergenstal RM, Miller KM, Beck RW, Weinstock RS, . PMID: 24855157.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    62. "We are all gonna get diabetic these days": the impact of a living legacy of type 2 diabetes on Hispanic young adults' diabetes care. Diabetes Educ. 2014 Sep-Oct; 40(5):648-58. Pyatak EA, Florindez D, Peters AL, Weigensberg MJ. PMID: 24867918.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    63. Translating the Diabetes Prevention Program into an Online Social Network: Validation against CDC Standards. Diabetes Educ. 2014 07; 40(4):435-443. Sepah SC, Jiang L, Peters AL. PMID: 24723130.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    64. Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial. Ann Emerg Med. 2014 Jun; 63(6):745-54.e6. Arora S, Peters AL, Burner E, Lam CN, Menchine M. PMID: 24225332.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    65. Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes. Aging Clin Exp Res. 2014 Apr; 26(2):115-21. Jovanovic L, Peters AL, Jiang HH, Hardin DS. PMID: 24092662.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    66. Continuous glucose monitoring pilot in low-income type 1 diabetes patients. Diabetes Technol Ther. 2013 Oct; 15(10):855-8. Sequeira PA, Montoya L, Ruelas V, Xing D, Chen V, Beck R, Peters AL. PMID: 23865840.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    67. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab. 2013 Aug; 98(8):3411-9. Weinstock RS, Xing D, Maahs DM, Michels A, Rickels MR, Peters AL, Bergenstal RM, Harris B, Dubose SN, Miller KM, Beck RW, . PMID: 23760624.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    68. Intensive weight loss intervention in older individuals: results from the Action for Health in Diabetes Type 2 diabetes mellitus trial. J Am Geriatr Soc. 2013 Jun; 61(6):912-22. Espeland MA, Rejeski WJ, West DS, Bray GA, Clark JM, Peters AL, Chen H, Johnson KC, Horton ES, Hazuda HP, . PMID: 23668423.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    69. Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis. J Med Econ. 2013; 16(4):529-38. Eby EL, Wang P, Curtis BH, Xie J, Haldane DC, Idris I, Peters AL, Hood RC, Jackson JA. PMID: 23363330.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    70. Challenges in applying diabetes technology to clinical care. Diabetes Technol Ther. 2012 Oct; 14(10):849-50. Peters AL. PMID: 23013199.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    71. Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens. Am J Manag Care. 2012 Sep; 18(8 Suppl):s191-202. Best JH, Romley JA, Goldman DP, Conrad RM, Peters AL. PMID: 23039898.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    72. Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population. Diabetes Technol Ther. 2012 Oct; 14(10):904-11. Romley JA, Goldman DP, Solomon M, McFadden D, Peters AL. PMID: 22845701.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    73. A mobile health intervention for inner city patients with poorly controlled diabetes: proof-of-concept of the TExT-MED program. Diabetes Technol Ther. 2012 Jun; 14(6):492-6. Arora S, Peters AL, Agy C, Menchine M. PMID: 22524591.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    74. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012 Jun; 35(6):1364-79. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, , . PMID: 22517736.
      View in: PubMed   Mentions: 1002     Fields:    Translation:Humans
    75. Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial. J Bone Miner Res. 2012 Mar; 27(3):619-27. Schwartz AV, Johnson KC, Kahn SE, Shepherd JA, Nevitt MC, Peters AL, Walkup MP, Hodges A, Williams CC, Bray GA, . PMID: 22354851.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    76. Trends in diabetes-related visits to US EDs from 1997 to 2007. Am J Emerg Med. 2012 Jun; 30(5):754-8. Menchine MD, Wiechmann W, Peters AL, Arora S. PMID: 21570241.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    77. Incretin-based therapies: review of current clinical trial data. Am J Med. 2010 Mar; 123(3 Suppl):S28-37. Peters A. PMID: 20206729.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    78. Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk. Cleve Clin J Med. 2009 Dec; 76 Suppl 5:S20-7. Peters AL. PMID: 19952300.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    79. Clinical practice in type 2 diabetes: After metformin and lifestyle, then what? J Fam Pract. 2009 Nov; 58(11 Suppl Clinical):S7-14. Cobble ME, Peters AL. PMID: 19891948.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    80. A piece of my mind. Clinic of tears. JAMA. 2009 Jun 10; 301(22):2309. Peters A. PMID: 19509369.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    81. Food and park environments: neighborhood-level risks for childhood obesity in east Los Angeles. J Adolesc Health. 2007 Apr; 40(4):325-33. Kipke MD, Iverson E, Moore D, Booker C, Ruelas V, Peters AL, Kaufman F. PMID: 17367725.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimals
    82. Case study 2: new insights: clinical pearls for using incretin mimetics in type 2 diabetes. Diabetes Educ. 2007 Jan-Feb; 33 Suppl 1:14S-19S. Peters AL, Miller D. PMID: 17272804.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    83. Identification of appropriate patients for cardiometabolic risk management. Rev Cardiovasc Med. 2007; 8 Suppl 4:S9-16. Peters AL. PMID: 17934394.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. Short and longer term outcomes of a diabetes disease management program in underserved Latino patients. Curr Med Res Opin. 2005 Dec; 21(12):1935-41. Mathur R, Roybal GM, Peters AL. PMID: 16368043.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    Anne's Networks
    Concepts (283)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (26)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑